2013
Anti-Pfs25 Human Plasma Reduces Transmission of Plasmodium falciparum Isolates That Have Diverse Genetic Backgrounds
Da D, Dixit S, Sattabonkot J, Mu J, Abate L, Ramineni B, Ouedraogo J, MacDonald N, Fay M, Su X, Cohuet A, Wu Y. Anti-Pfs25 Human Plasma Reduces Transmission of Plasmodium falciparum Isolates That Have Diverse Genetic Backgrounds. Infection And Immunity 2013, 81: 1984-1989. PMID: 23509152, PMCID: PMC3676035, DOI: 10.1128/iai.00016-13.Peer-Reviewed Original ResearchConceptsPhase 1 trialParasite isolatesMalaria transmission-blocking vaccineTransmission-reducing activityTransmission-blocking activityPlasmodium falciparum isolatesTransmission-blocking vaccinesPlasmodium falciparum parasitesLimited sequence polymorphismPfs25 antibodiesMontanide ISA51Immune plasmaNonimmune controlsRecombinant Pfs25Falciparum isolatesPfs25 geneFalciparum parasitesGenetic backgroundPatientsBurkina FasoPfs25VaccineTrialsNucleotide polymorphismsIsolates
1980
Vaccination for the Prevention of Maternal and Fetal Infection with Guinea Pig Cytomegalovirus
Bia F, Griffith B, Tarsio M, Hsiung G. Vaccination for the Prevention of Maternal and Fetal Infection with Guinea Pig Cytomegalovirus. The Journal Of Infectious Diseases 1980, 142: 732-738. PMID: 6257798, DOI: 10.1093/infdis/142.5.732.Peer-Reviewed Original ResearchConceptsFetal infectionAcute viremiaPregnant animalsGuinea pigsGuinea pig cytomegalovirusCMV vaccineAntigen vaccineNonimmune controlsCytomegalovirus vaccineLower incidenceControl animalsImmunized animalsVaccinated animalsCMVViremiaVaccineVirulent virusInfectionSerial passageAnimalsPigsDense bodiesTissue cultureVaccinationCytomegalovirus
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply